Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
17-20 March, 2025
Pharma, Lab & Chemical...Pharma, Lab & Chemical Expo
Not Confirmed
Not Confirmed
03-05 January, 2025
Not Confirmed
Not Confirmed
07-09 January, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
17-20 March, 2025
Pharma, Lab & Chemical...Pharma, Lab & Chemical Expo
Industry Trade Show
Not Confirmed
03-05 January, 2025
Industry Trade Show
Not Confirmed
07-09 January, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/translational-pharmaceutics-our-flagship-platform-for-drug-development-empowers-our-clients-with-unparalleled-flexibility
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-bora-polpharma-make-acquisitions-evonik-euroapi-porton-announce-technological-expansions
04 Sep 2023
// BIOSPECTRUM ASIA
https://www.biospectrumasia.com/news/25/22966/japanese-pharma-firm-otsuka-buys-mindset-pharma-for-cad-80-m-to-strengthen-pipeline-in-neurological-disorders.html
01 Sep 2023
// BIOSPACE
https://www.biospace.com/article/releases/otsuka-pharmaceutical-to-acquire-mindset-pharma/?s=61
28 Jun 2023
// Catherine Eckford EUROPEAN PHARMACEUTICAL REVIEW
https://www.europeanpharmaceuticalreview.com/news/184038/uk-trial-to-test-psilocin-based-drug-for-major-depressive-disorder/
26 Apr 2023
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2023/04/26/2654867/0/en/Mindset-Pharma-Files-Two-Patent-Applications-for-its-Non-Hallucinogenic-Non-Tryptamine-Compounds.html
03 Apr 2023
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2023/04/03/2639404/0/en/Mindset-Pharma-to-Participate-in-the-Sequire-Cannabis-Psychedelics-Conference-on-Wednesday-April-5-2023.html
28 Mar 2023
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2023/03/28/2635529/0/en/Mindset-Pharma-CEO-James-Lanthier-Issues-Letter-to-Shareholders-Discussing-Expansion-of-Drug-Discovery-Efforts-into-Novel-Non-Hallucinogenic-Therapeutics.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?